Aktis Oncology, Inc. Common stock (AKTS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for AKTS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 109 institutions reported holding AKTS, with 34.1 million shares worth $1.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Mpm Bioimpact | 4,835,872 | $156M | UNCHANGED |
| Ecor1 Capital | 4,824,469 | $155M | UNCHANGED |
| Blue Owl Capital Holdings | 3,070,219 | $99M | DECREASED |
| T. Rowe Price | 2,814,946 | $91M | DECREASED |
| BlackRock | 2,278,358 | $73M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Aktis Oncology, Inc. Common stock on SentiSense.